Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study.


Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
09 2023
Historique:
received: 26 04 2023
accepted: 09 06 2023
medline: 14 9 2023
pubmed: 11 7 2023
entrez: 11 7 2023
Statut: ppublish

Résumé

The Acute Disease Quality Initiative (ADQI) Workgroup recently released a consensus definition of sepsis-associated acute kidney injury (SA-AKI), combining Sepsis-3 and Kidney Disease Improving Global Outcomes (KDIGO) AKI criteria. This study aims to describe the epidemiology of SA-AKI. This is a retrospective cohort study carried out in 12 intensive care units (ICUs) from 2015 to 2021. We studied the incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes of SA-AKI based on the ADQI definition. Out of 84,528 admissions, 13,451 met the SA-AKI criteria with its incidence peaking at 18% in 2021. SA-AKI patients were typically admitted from home via the emergency department (ED) with a median time to SA-AKI diagnosis of 1 day (interquartile range (IQR) 1-1) from ICU admission. At diagnosis, most SA-AKI patients (54%) had a stage 1 AKI, mostly due to the low urinary output (UO) criterion only (65%). Compared to diagnosis by creatinine alone, or by both UO and creatinine criteria, patients diagnosed by UO alone had lower renal replacement therapy (RRT) requirements (2.8% vs 18% vs 50%; p < 0.001), which was consistent across all stages of AKI. SA-AKI hospital mortality was 18% and SA-AKI was independently associated with increased mortality. In SA-AKI, diagnosis by low UO only, compared to creatinine alone or to both UO and creatinine criteria, carried an odds ratio of 0.34 (95% confidence interval (CI) 0.32-0.36) for mortality. SA-AKI occurs in 1 in 6 ICU patients, is diagnosed on day 1 and carries significant morbidity and mortality risk with patients mostly admitted from home via the ED. However, most SA-AKI is stage 1 and mostly due to low UO, which carries much lower risk than diagnosis by other criteria.

Identifiants

pubmed: 37432520
doi: 10.1007/s00134-023-07138-0
pii: 10.1007/s00134-023-07138-0
pmc: PMC10499944
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1079-1089

Investigateurs

Mahesh Ramanan (M)
Prashanti Marella (P)
Patrick Young (P)
Pip McIlroy (P)
Ben Nash (B)
James McCullough (J)
Mandy Tallott (M)
Andrea Marshall (A)
David Moore (D)
Hayden White (H)
Sunil Sane (S)
Lynette Morrison (L)
Pam Dipplesman (P)
Stephen Luke (S)
Anni Paasilahti (A)
Ray Asimus (R)
Jennifer Taylor (J)
Kyle White (K)
David Cook (D)
Peter Kruger (P)
Jason Meyer (J)
Rod Hurford (R)
Kevin Plumpton (K)
Andrew Barlow (A)
Alexis Tabah (A)
Hamish Pollock (H)
Patrick Young (P)
Antony G Attokaran (AG)
Jacobus Poggenpoel (J)
Josephine Reoch (J)
Kevin B Laupland (KB)
Felicity Edwards (F)
Jayesh Dhanani (J)
Marianne Kirrane (M)
Pierre Clement (P)
Nermin Karamujic (N)
Paula Lister (P)
Vikram Masurkar (V)
Lauren Murray (L)
Jane Brailsford (J)
Todd Erbacher (T)
Kiran Shekar (K)
Jayshree Lavana (J)
George Cornell (G)
Siva Senthuran (S)
Stephen Whebell (S)
Gail Henson (G)
Michelle Gatton (M)
Zephanie Tyack (Z)
Robert Andrews (R)
Arthur Ter Hofstede (A)
Moe Wynn (M)
Kevin B Laupland (KB)
Felicity Edwards (F)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

Finfer S, Machado FR (2016) The global epidemiology of sepsis. Does it matter that we know so little? Am J Resp Crit Care 193(3):228–230
doi: 10.1164/rccm.201510-1976ED
Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al (2006) Sepsis in European intensive care units and colon; results of the SOAP study and ast. Crit Care Med 34(2):344–353
doi: 10.1097/01.CCM.0000194725.48928.3A pubmed: 16424713
Chiu C, Legrand M (2021) Epidemiology of sepsis and septic shock. Curr Opin Anaesthesiol 34(2):71–76
doi: 10.1097/ACO.0000000000000958 pubmed: 33492864
Poston JT, Koyner JL (2019) Sepsis associated acute kidney injury. BMJ 364:k4891
doi: 10.1136/bmj.k4891 pubmed: 30626586 pmcid: 6890472
Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA (2019) Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96(5):1083–1099
doi: 10.1016/j.kint.2019.05.026 pubmed: 31443997 pmcid: 6920048
Bagshaw SM, George C, Bellomo R, Committee ADM (2008) Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 12(2):R47
doi: 10.1186/cc6863 pubmed: 18402655 pmcid: 2447598
Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M et al (2007) Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephro 2(3):431–439
doi: 10.2215/CJN.03681106
Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M et al (2023) Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol. https://doi.org/10.1038/s41581-023-00683-3
doi: 10.1038/s41581-023-00683-3 pubmed: 37653237
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810
doi: 10.1001/jama.2016.0287 pubmed: 26903338 pmcid: 4968574
Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179–c184
doi: 10.1159/000339789 pubmed: 22890468
Bagshaw SM, George C, Bellomo R, Committe ADM (2008) A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transpl 23(5):1569–1574
doi: 10.1093/ndt/gfn009
Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R et al (2017) Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 317(3):290–300
doi: 10.1001/jama.2016.20328 pubmed: 28114553
Corrigan C, Duke G, Millar J, Paul E, Butt W, Gordon M et al (2022) Admissions of children and adolescents with deliberate self-harm to intensive care during the SARS-CoV-2 outbreak in australia. Jama Netw Open 5(5):e2211692
doi: 10.1001/jamanetworkopen.2022.11692 pubmed: 35544133 pmcid: 9096595
Kirsi-Maija K, Michael B, David P, Jamie CD, Rinaldo B (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. New Engl J Med 372(17):1629–1638
doi: 10.1056/NEJMoa1415236
Lambden S, Laterre PF, Levy MM, Francois B (2019) The SOFA score—development, utility and challenges of accurate assessment in clinical trials. Crit Care 23(1):374
doi: 10.1186/s13054-019-2663-7 pubmed: 31775846 pmcid: 6880479
Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):762–774
doi: 10.1001/jama.2016.0288 pubmed: 26903335 pmcid: 5433435
Shah AD, MacCallum NS, Harris S, Brealey DA, Palmer E, Hetherington J et al (2021) Descriptors of sepsis using the sepsis-3 criteria: a cohort study in critical care units within the UK National Institute for Health Research critical care health informatics collaborative. Crit Care Med 49(11):1883–1894
doi: 10.1097/CCM.0000000000005169 pubmed: 34259454 pmcid: 8508729
Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA et al (2014) Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis 14(12):1220–1227
doi: 10.1016/S1473-3099(14)70952-1 pubmed: 25455989 pmcid: 5525058
Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS et al (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):775–787
doi: 10.1001/jama.2016.0289 pubmed: 26903336 pmcid: 4910392
Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H et al (2017) Angiotensin II for the treatment of vasodilatory shock. New Engl J Medicine 377(5):419–430
doi: 10.1056/NEJMoa1704154
Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. New Engl J Med 385(19):1737–1749
doi: 10.1056/NEJMoa2102953 pubmed: 34554658
Cooper DJ, Plewes K, Grigg MJ, Patel A, Rajahram GS, William T et al (2021) An evaluation of commonly used surrogate baseline creatinine values to classify AKI during acute infection. Kidney Int Rep 6(3):645–656
doi: 10.1016/j.ekir.2020.12.020 pubmed: 33732979 pmcid: 7938202
Katayama S, Nunomiya S, Koyama K, Wada M, Koinuma T, Goto Y et al (2017) Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin. Crit Care 21(1):229
doi: 10.1186/s13054-017-1815-x pubmed: 28841902 pmcid: 5574079
Gameiro J, Gonçalves M, Pereira M, Rodrigues N, Godinho I, Neves M et al (2018) Obesity, acute kidney injury and mortality in patients with sepsis: a cohort analysis. Ren Fail 40(1):120–126
doi: 10.1080/0886022X.2018.1430588 pubmed: 29388454 pmcid: 6014496
Bernier-Jean A, Beaubien-Souligny W, Goupil R, Madore F, Paquette F, Troyanov S et al (2017) Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values. Bmc Nephrol 18(1):141
doi: 10.1186/s12882-017-0552-3 pubmed: 28454562 pmcid: 5410063
Bagshaw SM, Neto AS, Smith O, Weir M, Qiu H, Du B et al (2022) Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial. Intensive Care Med 48:1736
doi: 10.1007/s00134-022-06912-w pubmed: 36331570
White K, Tabah A, Ramanan M, Shekar K, Edwards F, Laupland KB (2023) 90-day case-fatality in critically ill patients with chronic liver disease influenced by presence of portal hypertension, results from a multicentre retrospective cohort study. J Crit Care 1(38):5–10

Auteurs

Kyle C White (KC)

Intensive Care Unit, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia. kyle.white@health.qld.gov.au.
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. kyle.white@health.qld.gov.au.
Queensland University of Technology (QUT), Brisbane, QLD, Australia. kyle.white@health.qld.gov.au.

Ary Serpa-Neto (A)

Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.

Rod Hurford (R)

Intensive Care Unit, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia.

Pierre Clement (P)

Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Kevin B Laupland (KB)

Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Emily See (E)

School of Medicine, University of Melbourne, Melbourne, Australia.
Department of Critical Care, University of Melbourne, Melbourne, Australia.
Department of Intensive Care, Austin Hospital, Heidelberg, Australia.
Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia.
Department of Nephrology, The Royal Children's Hospital, Parkville, Australia.

James McCullough (J)

Intensive Care Unit, Gold Coast University Hospital, Southport, QLD, Australia.

Hayden White (H)

Intensive Care Unit, Logan Hospital, Logan, QLD, Australia.
School of Medicine and Dentistry, Griffith University, Mount Gravatt, QLD, Australia.

Kiran Shekar (K)

Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, QLD, Australia.

Alexis Tabah (A)

Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Intensive Care Unit, Redcliffe Hospital, Brisbane, QLD, Australia.

Mahesh Ramanan (M)

Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Intensive Care Unit, Caboolture Hospital, Caboolture, QLD, Australia.
Critical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Peter Garrett (P)

Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Intensive Care Unit, Sunshine Coast University Hospital, Birtinya, QLD, Australia.

Antony G Attokaran (AG)

Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Intensive Care Unit, Rockhampton Hospital, The Range, QLD, Australia.

Stephen Luke (S)

Intensive Care Services, Mackay Base Hospital, Mackay, QLD, Australia.
College of Medicine and Dentistry, James Cook University, Townsville, QLD, Australia.

Siva Senthuran (S)

College of Medicine and Dentistry, James Cook University, Townsville, QLD, Australia.
Intensive Care Unit, Townsville Hospital, Townsville, QLD, Australia.

Philippa McIlroy (P)

Intensive Care Unit, Cairns Hospital, Cairns, QLD, Australia.

Rinaldo Bellomo (R)

Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Department of Critical Care, University of Melbourne, Melbourne, Australia.
Department of Intensive Care, Austin Hospital, Heidelberg, Australia.
Department of Intensive Care,, Royal Melbourne Hospital, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH